Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)
India · Delayed Price · Currency is INR 32.65
+0.67 (2.10%)
At close: Jul 27, 2026
BOM:524396 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 527 | 421 | 669 | 982 | 674 | 941 | |
Market Cap Growth | -28.32% | -37.08% | -31.86% | 45.66% | -28.30% | -11.96% |
Enterprise Value | 524 | 418 | 672 | 987 | 678 | 944 |
Last Close Price | 32.40 | 25.88 | 41.13 | 60.36 | 41.44 | 57.80 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 18.95 | 15.12 | 120.02 | 138.51 | 120.34 | 134.68 |
PS Ratio | 1.68 | 1.34 | 1.99 | 2.43 | 2.25 | 4.20 |
PB Ratio | 2.45 | 1.95 | 3.56 | 5.40 | 3.90 | 5.59 |
P/TBV Ratio | 2.45 | 1.95 | 3.56 | 5.40 | 3.90 | 5.59 |
P/FCF Ratio | - | - | - | 41.43 | - | - |
P/OCF Ratio | - | - | - | 41.04 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.67 | 1.33 | 2.00 | 2.44 | 2.26 | 4.22 |
EV/EBITDA Ratio | 14.05 | 11.20 | 60.60 | 75.97 | 53.66 | 64.55 |
EV/EBIT Ratio | 15.15 | 12.08 | 92.16 | 109.68 | 81.27 | 91.23 |
EV/FCF Ratio | - | - | - | 41.65 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.14 | 0.14 | 0.03 | 0.02 | 0.03 | 0.03 |
Debt / EBITDA Ratio | 0.81 | 0.81 | 0.43 | 0.34 | 0.41 | 0.32 |
Debt / FCF Ratio | - | - | - | 0.19 | - | - |
Net Debt / Equity Ratio | -0.01 | -0.01 | 0.01 | -0.10 | 0.03 | 0.02 |
Net Debt / EBITDA Ratio | -0.08 | -0.08 | 0.20 | -1.42 | 0.38 | 0.22 |
Net Debt / FCF Ratio | 0.38 | 0.38 | -0.11 | -0.78 | -3.96 | -1.10 |
Asset Turnover | 0.67 | 0.67 | 0.69 | 1.03 | 1.20 | 0.86 |
Inventory Turnover | 6.48 | 6.48 | 9.49 | 17.40 | 18.18 | 5.60 |
Quick Ratio | 1.49 | 1.49 | 1.21 | 1.24 | 1.50 | 5.03 |
Current Ratio | 1.73 | 1.73 | 1.34 | 1.35 | 1.63 | 6.23 |
Return on Equity (ROE) | 13.81% | 13.81% | 3.02% | 4.00% | 3.28% | 4.24% |
Return on Assets (ROA) | 4.61% | 4.61% | 0.93% | 1.43% | 2.08% | 2.49% |
Return on Invested Capital (ROIC) | 13.23% | 13.88% | 3.12% | 4.32% | 3.37% | 4.28% |
Return on Capital Employed (ROCE) | 15.60% | 15.60% | 3.80% | 4.90% | 4.70% | 6.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 5.28% | 6.62% | 0.83% | 0.72% | 0.83% | 0.74% |
FCF Yield | -1.53% | -1.91% | -3.02% | 2.41% | -0.18% | -0.31% |
Buyback Yield / Dilution | -0.11% | -0.11% | - | - | - | - |